Y. Néron

Social disparities and patients’ attitudes are associated with lower rates of cervical cancer screening in Brazil: Results of EVITA study (LACOG 0215).

F. Zaffaroni, G. Werutsky, K. Torres, 2018 .

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4).

R. Motzer, D. Ye, B. Alekseev, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC).

R. Motzer, S. Segal, Liping Xie, 2015 .

Abstract P4-12-26: A phase II randomized study of lapatinib in combination with capecitabine, vinorelbine or gemcitabine as first or second line-therapy in patients with HER2 positive metastatic breast cancer progressing after taxane (LACOG 0801)

H. Gómez, C. Barrios, G. Werutsky, 2013 .

Abstract P6-16-04: Real World data and patterns of care of metastatic breast cancer (MBC) in Brazil: First results of LACOG 0312 retrospective study

C. Barrios, F. Zaffaroni, G. Werutsky, 2017 .